首页> 外文期刊>ORL: Journal for oto-rhino-laryngology and its borderlands >The treatment of distant metastases in head and neck cancer--present and future.
【24h】

The treatment of distant metastases in head and neck cancer--present and future.

机译:目前和未来头颈癌远处转移的治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

At the present time the occurrence of distant metastases in patients with head and neck squamous cell carcinoma means that lifespan is measured in months. In most instances treatment is purely palliative. Isolated lung metastasis can be successfully removed with long-term disease control in selected patients. Radiotherapy can be useful for palliation of bone metastases and occasionally lung or brain metastases. Chemotherapy does not have a major impact at the present time except for the treatment of metastases from nasopharyngeal cancer. Palliative symptomatic care, along with appropriate pain control, is essential since pain management is very important in these patients. A significant change in the survival of patients with head and neck cancer is only likely to occur by the development of new approaches to treatment. Blocking tumor angiogenesis and treatment based on genetic abnormalities or cell surface receptors offer the two strategies that are most likely to be successful. Copyright 2001 S. Karger AG, Basel
机译:目前,头颈部鳞状细胞癌患者发生远处转移意味着寿命以月为单位。在大多数情况下,治疗纯粹是姑息治疗。长期选择的患者可以通过长期的疾病控制成功地消除孤立的肺转移。放射疗法可用于缓解骨转移瘤,偶尔可用于肺或脑转移瘤。目前,化学疗法除了治疗鼻咽癌转移瘤外,尚无重大影响。姑息对症治疗以及适当的疼痛控制至关重要,因为在这些患者中疼痛管理非常重要。头颈癌患者生存率的重大变化只有通过开发新的治疗方法才可能发生。基于遗传异常或细胞表面受体阻断肿瘤血管生成和治疗提供了最有可能成功的两种策略。版权所有2001 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号